Handbook of Clinical medicine

Treatment: WHO public health strategy SAFE: surgery to treat blinding disease (trichiasis), antibiotics (azithromycin) to clear infection (mass administration in en- demic areas through International Trachoma Initiative), facial cleanliness, environ- mental improvement with access to water and sanitation.12 (a) (b) (c) Fig 9.47 (a) Follicular trachoma. (b) Scarring. (c) Trichiasis. Reproduced from Warrell et al., Oxford Textbook of Medicine, 2010, with permission from Oxford University Press. Immunosuppression and the eye • Herpes zoster ophthalmicus: Due to reactivation of latent varicella zoster virus (p404) in the ophthalmic branch of the trigeminal nerve.  Risk of reactivation and ocular complications in immunosuppression: HIV, post-transplantation. Presentation: vesiculomacular skin rash and dysaes- thesia in ophthalmic division of the trigeminal nerve (fi g 9.48). Hutchinson’s sign = lesion at tip/side of nose indicates involvement of nasociliary branch of V1 and chance of eye involvement. Complications: corneal Fig 9.48 Herpes zoster ophthalmicus. opacifi cation, uveitis, ocular nerve palsy, eyelid de- ©MN Oxman , University of California. formity, optic neuritis, post-herpetic neuralgia. Can be sight-threatening  recognition and urgent treatment are required. Diagnosis: clinical. Antibody staining/PCR of skin scrapings. Treatment: oral famciclovir/valacyclovir or systemic aciclovir reduce complications if given within 72h of symptoms. Analgesia. If retinitis IV
